BRIEF published on 08/20/2025 at 23:35, 9 months 28 days ago Medicure Reports Q2 2025 Financial Results Financial Results Net Loss Net Revenue Research Investment Pharmaceutical Business
PRESS RELEASE published on 08/20/2025 at 23:30, 9 months 28 days ago Medicure Reports Financial Results for Quarter Ended June 30, 2025 Medicure Inc. reports Q2 2025 financial results, including increased revenue from Marley Drug and ZYPITAMAG(R), and enhanced adjusted EBITDA. Find full details at www.medicure.com Financial Results Medicure Inc. Marley Drug ZYPITAMAG Q2 2025
BRIEF published on 08/18/2025 at 23:35, 9 months 30 days ago Medicure to Announce Q2 2025 Financial Results via Conference Call Financial Results Conference Call Pharmaceuticals Medicure Q2 2025
PRESS RELEASE published on 08/18/2025 at 23:30, 9 months 30 days ago Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025 Medicure Inc. to present Financial Results for Q2 2025 on August 21, 2025 via conference call. Operations and products focus detailed Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 06/17/2025 at 23:05, 1 year ago Medicure Finalizes Acquisition of West Olympia Pharmacy Acquisition Revenue Growth Pharmaceuticals Pharmacy Medicure
PRESS RELEASE published on 06/17/2025 at 23:00, 1 year ago Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy Medicure Inc. announces acquisition of West Olympia Pharmacy Inc., further boosting direct-to-consumer pharmacy business and sales of ZYPITAMAG(R) and BRENZAVVY(R) Acquisition Medicure Inc. Pharmacy Business ZYPITAMAG(R) BRENZAVVY(R)
BRIEF published on 05/21/2025 at 23:05, 1 year ago Medicure Announces Q1 2025 Financial Results and Director Election Outcomes Net Loss Director Election Medicure Financial Results AGGRASTAT Sales Decline Pharmacy Revenue
PRESS RELEASE published on 05/21/2025 at 23:00, 1 year ago Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results Medicure Inc. reports Q1 2025 results with $5.5M net revenue, elects directors, and details financial performance. AGGRASTAT and ZYPITAMAG sales analyzed Medicure Inc. Net Revenue AGGRASTAT ZYPITAMAG Q1 2025 Results
BRIEF published on 04/25/2025 at 23:06, 1 year 1 month ago Medicure Inc. Reveals Financial Results for 2024 Medicure Inc. 2024 AGGRASTAT® Sales ZYPITAMAG® Revenue Marley Drug Financials Adjusted EBITDA Decline
PRESS RELEASE published on 04/25/2025 at 23:01, 1 year 1 month ago Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024 Medicure Inc. reports total net revenue of $21.9 million for year ended Dec 31, 2024. AGGRASTAT & Marley Drug sales increase, while Adjusted EBITDA declines Adjusted EBITDA Medicure Inc. Marley Drug Net Revenue AGGRASTAT
Published on 06/18/2026 at 00:00, 24 minutes ago LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 54 minutes ago Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 1 hour 34 minutes ago International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 1 hour 54 minutes ago Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 7 hours 29 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/17/2026 at 21:40, 2 hours 44 minutes ago Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 19:10, 5 hours 14 minutes ago Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:40, 5 hours 44 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2026 at 18:36, 5 hours 48 minutes ago BILENDI: Bilendi announces that Euroland Corporate has initiated coverage of its shares
Published on 06/17/2026 at 18:23, 6 hours 1 minute ago EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Conclusion of a delisting agreement with Bayerische Gewerbebau AG
Published on 06/17/2026 at 17:40, 6 hours 44 minutes ago Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 15 hours 39 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 12 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 1 hour ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 5 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
